课题基金 / 基金详情

Predicting and Evaluating Anal Cancer in HIV with novel biomarkers: The PEACH Study

Predicting and Evaluating Anal Cancer in HIV with novel biomarkers: The PEACH Study
使用新型生物标志物预测和评估 HIV 患者肛门癌：PEACH 研究
批准号：
419916
负责人：
Grennan Jonathan (Troy)
金额：
$66.88万
依托单位：
B.C. Centre for Disease Control (Vancouver)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-03-01 至 2024-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=419916&lang=en
关键词：
Anal Cancer Anal Cancer Screening Biomarkers Clinical Epidemiology Diagnostic Tests Human Immunodeficiency Virus (Hiv) Human Papillomavirus (Hpv) Men Who Have Sex With Men (Msm) Sexually Transmitted Infections (Stis)

项目摘要

项目成果

Grennan Jonathan (Troy)的其他基金

相似基金

相关文献

中文摘要
翻译
虽然自20世纪90年代中期首次出现有效的治疗方法以来，艾滋病毒携带者的健康状况有了许多改善，包括艾滋病相关癌症的减少，但自那时以来，其他类型的癌症也有所增加。
英文摘要
Though there have been many improvements in the health of those living with HIV since the mid 1990s when effective therapies first emerged including reductions in AIDS-associated cancers, there have been increases in other types of cancer since that time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A randomized trial of doxycycline chemoprophylaxis for the prevention of sexually transmitted infections in gay, bisexual and other men who have sex with men (gbMSM)
Predicting and Evaluating Anal Cancer in HIV with novel biomarkers: The PEACH Study
Prevention of STIs and Other Comorbidities in HIV-Positive Men Who Have Sex with Men (PRESTO-HIV)
  • 批准号：
    367839
  • 项目类别：
    Operating Grants
  • 资助金额：
    $1.82万
  • 财政年份：
    2017
  • 负责人：
    Grennan Jonathan (Troy)
  • 依托单位：
    University of British Columbia
A randomized, placebo-controlled trial of oral doxycycline for the prevention of syphilis in men who have sex with men (MSM)
  • 批准号：
    351808
  • 项目类别：
    Operating Grants
  • 资助金额：
    $7.29万
  • 财政年份：
    2016
  • 负责人：
    Grennan Jonathan (Troy)
  • 依托单位：
    University of British Columbia
海外基金